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O B J E C T I V E S This study was carried out to detect vulnerable coronary plaques by color ﬂuorescent
angioscopy.
B A C KG ROUND Collagen ﬁbers (CFs) mainly provide mechanical support to coronary plaques.
Oxidized low-density lipoprotein (Ox-LDL) induces macrophage proliferation, which in turn destroy CFs
while accumulating lipids. As such, demonstration of the absence of CFs, deposition of lipids, and the
Ox-LDL may suggest plaque instability.
METHOD S Fluorescence of the major components of the atherosclerotic plaques was examined by
ﬂuorescent microscopy using a 345-nm band-pass ﬁlter and 420-nm band-absorption ﬁlter (A-imaging).
Fluorescence of Ox-LDL was examined using a 470-nm band-pass ﬁlter and 515-nm band-absorption
ﬁlter (B-imaging) and Evans blue dye as an indicator. Fluorescence in 57 excised human coronary
plaques was examined by A-imaging color ﬂuorescent angioscopy. Oxidized LDL in 31 excised coronary
plaques and in 12 plaques of 7 patients was investigated by B-imaging color ﬂuorescent angioscopy.
R E S U L T S Collagen I, collagen IV, and calcium exhibited blue, light blue, and white autoﬂuorescence,
respectively. In the presence of beta-carotene which coexists with lipids in the vascular wall, collagen I
and IV exhibited green, collagen III and V white, cholesterol yellow, cholesteryl esters orange
ﬂuorescence. Oxidized LDL exhibited reddish brown ﬂuorescence in the presence of Evans blue dye.
Therefore, coronary plaques exhibited blue, green, white-to-light blue, or yellow-to-orange ﬂuorescence
based on plaque composition. Histological examination revealed abundant CFs without lipids in blue
plaques; CFs and lipids in green plaques; meager CFs and abundant lipids in white-to-light blue plaques;
and the absence of CFs and deposition of lipids, calcium, and macrophage foam cells in the thin ﬁbrous
cap in yellow-to-orange plaques, indicating that the yellow-to-orange plaques were most vulnerable.
Reddish brown ﬂuorescence characteristic of Ox-LDL was observed in excised coronary plaques, as also
in patients.
CONC L U S I O N S Color ﬂuorescent angioscopy provides objective information related to coronary
plaque composition and may help identify unstable plaques. (J Am Coll Cardiol Img 2010;3:398–408)
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399t is generally believed that the coronary plaques
with thin fibrous cap and a large lipid core beneath
are vulnerable, and imaging methods such as
intravascular ultrasonography (1), optical coher-
nce tomography (2), and angioscopy (3–5) have
een clinically employed to detect these types of
laques. However, the coronary plaques that have a
hin cap with superficial calcium deposition are
requently observed during post-mortem examina-
ions (3). Moreover, plaques wherein the deposition
f lipids and macrophages is confined to just the
uperficial layers and in which a lipid core is not
rominent also exist (3). As such, there is a neces-
ity of detailed molecular characterization of the
ulnerable plaques.
Oxidized low-density lipoprotein (Ox-LDL)
lays an important role in the initiation, progres-
ion, and destabilization of atherosclerotic plaques
y inducing the proliferation and prolongation of
urvival of macrophages (6,7). On the other hand,
ormal collagen fibers (CFs) that contain collagen I
n abundance protect the coronary plaques against
echanical stress. During plaque growth, collagen I
s replaced by collagen III, IV, and/or V (8–10),
nd CFs are degenerated, disrupted, and finally
estroyed by matrix metalloproteinases released by
acrophages (11). During this process, macro-
hages accumulate lipids such as cholesteryl esters
CEs) and Ox-LDL (12,13) and become foam cells
hile simultaneously producing ceramide within
hemselves (14); their death results in formation of
he lipid core (15). Therefore, demonstrating the
ack of collagen I, which is mainly contained in
ormal CFs, deposition of lipids, and existence of
x-LDL, suggests the likelihood of vulnerable
laques, but in vivo clinical tools to visualize them
n the coronary plaques are lacking.
E T H O D S
eﬁning plaque constituents by color ﬂuorescent
icroscopy. AUTO-FLUORESCENCE. The color
uorescence of the major substances that consti-
ute atherosclerotic plaques (Table 1) (16) was
xamined by color fluorescent microscopy (CFM)
ystem (IX 70, Olympus Co., Tokyo, Japan) using
345  10-nm band-pass filter (BPF), a 420-nm
ichroic membrane (DM), and a 420-nm band-
bsorption filter (BAF). This combination of BPF,
M, and BAF for A-imaging of fluorescence was
mployed because the fluorescent color of collagens
nd lipid components was most clearly distinguish-
ble. Subsequently, beta-carotene, which coexists iith lipids in the human vascular wall, was diluted
n glycerin at 10–5 mol/l and was mixed with the
tudied substances for fluorescent imaging.
x-LDL. Discrimination of color fluorescence spe-
ific to Ox-LDL was not successful by A-imaging.
herefore, a combination of 470-nm BPF, 515-nm
M, and 515-nm BAF (B-imaging) was employed
or imaging Ox-LDL using Evans blue dye (EB) as
n indicator because this dye has been clinically
sed for intravascular imaging (3,17), and its ben-
ficial effects proved (18,19).
olor ﬂuorescent angioscopy system. The color flu-
rescent angioscopy (CFA) system was composed
f a fluorescence excitation and emission units
developed in collaboration with Olympus Co.,
okyo, Japan), an angioscope (modified VecMover,
linical Supply Co., Gifu, Japan), and a color 3
harge-coupled device camera (C7780, Hamamatsu
hotonics Co., Hamamatsu, Japan).
To observe the vascular lumen, the light
nd image guides were connected to the
xcitation and emission units, respectively.
fter selecting the desired BPF and BAF,
he light was irradiated through the BPF
nd the light guide toward the target. The
voked fluorescence was received by the
amera through the DM and BAF for
uccessive 2-dimensional imaging at an
dequate time interval from 0.01 to 1 s.
The intensity of the fluorescence images
as arbitrarily defined as strong, weak,
nd absent when the exposure time re-
uired for imaging was within 0.5 s, over
.5 s, and within 1.0 s and over 1.0 s,
espectively. The details of this CFA sys-
em were described elsewhere (3).
xamination of excised human coronary arteries by
onventional angioscopy and CFA. This in vitro
tudy was performed with the approval of the
thical committees of Chiba-Kensei Hospital
Chiba, Japan) and Toho University Sakura Hos-
ital (Sakura, Japan) where autopsy was performed.
After obtaining the informed consent of the con-
erned families, 40 coronary arteries were excised from
6 cadavers (age: 63.1  2.4 years [mean  SE];
auses of death: hepatocellular carcinoma in 7,
oronary heart disease in 5, renal failure in 5, lung
ancer in 3, gastrointestinal cancer in 2, cerebral
nfarction in 2, and cerebral bleeding in 2).
A Y-connector was introduced into the proximal
ortion of the coronary artery, which was perfused
ith saline solution. An angioscope was introduced
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400ONVENTIONAL ANGIOSCOPY. Initially, white
ight was directly irradiated into the artery and the
mages were received by a color 3 charge-coupled
evice camera (CSVEC-10, Clinical Supply, Gifu,
apan) for conventional angioscopy of the targeted
laque. The light of the angioscope was seen
hrough the coronary wall, so the angioscope tip
nd, accordingly, the targeted plaque could be
onfirmed. Plaques and normal segments were de-
ned as previously described (3).
LAQUE COLOR MEASUREMENT FOR CONVEN-
IONAL ANGIOSCOPY. Plaque images that were ob-
ained by conventional angioscopy were classified
nto white and yellow in color by an AquaCosmos
mage analyzer (C7746, Hamamatsu Photonics
o., Hamamatsu, Japan). That is, a window was set
Table 1. Color Fluorescence of the Major Substances Present in
Substances
A-Im
Autoﬂuorescence
Collagen I B
Collagen IV LB
Collagen III, V —
Cholesterol W
Cholesteryl esters
Cholesteryl oleate —
Cholesteryl linoleate —
7-ketocholesterol —
5-Cholesten-3-beta-ol —
Oleic acid —
Triglyceride —
Oxidized low-density lipoprotein —
Low-density lipoprotein —
Very low-density lipoprotein —
High-density lipoprotein —
Phosphatidylcholine —
L(a)-Lysophosphatidyl- choline —
Apolipoprotein B-100 —
Apolipoprotein A-1 —
Apolipoprotein E-2 —
Matrix metalloproteinase-9 —
Heparan sulfate —
Hyaluronic acid —
Essential amino acids —
Albumin —
Globulins —
Calcium phosphate W
Ceramide P
Beta carotene O
—  no ﬂuorescence; B  blue; CFM  color ﬂuorescent microscopy; EB  Eva
R  red; RB  reddish brown; W  white; Y  yellow.n the appropriate portion of a plaque image. The wolor within the window was separated into 3
rimary colors, namely red, green, and blue. The
laque was defined as “white plaque” when the color
ntensity ratio (red:green:blue) was 1.0:0.9 to 1.1:
.9 to 1.1. Also, the plaque was defined as “yellow
laque” when the color intensity ratio (red : green :
lue) was 1.0:0.8 to 1.2:0.3 to 0.6.
UTOFLUORESCENCE IN PLAQUES BY CFA. After
xamination by conventional angioscopy, the image
uide was connected to a fluorescent emitter, and BPF
nd BAF for A-imaging were set to capture images by
FA without changing the position of the angioscope
ip in 25 coronary arteries.
x-LDL IN THE PLAQUES BY CFA. After observation
y conventional angioscopy, the BPF and BAF
erosclerotic Plaques by CFM
g B-Imaging
Beta Carotene Autoﬂuorescence EB
G G G
G G G
W–LB — —
Y Y O
O — —
O — —
O — —
O — —
Y — —
LY — —
— — RB
— — R
— — R
— — R
— — O
— — —
— — R
— — —
— — —
— — —
— — —
— — —
— — —
— — —
— — —
W Y —
— Y —
— O O
lue dye; G  green; LB  light blue; LY  light yellow; O  orange; P  pink;Ath
agin
ns bere set for B-imaging without changing the posi-
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401ion of the angioscope tip. After stopping the
erfusion of saline solution, 0.5 ml of 2% EB
olution was injected into the perfusion circuit in 15
oronary arteries. After 5 min, the perfusion of
aline solution was restarted, and the target plaque
as observed.
A preliminary in vitro study revealed that this
FA system can visualize fluorescence from a target
ocated within a depth of 200 m from the plaque
urface.
FM scanning. AUTOFLUORESCENCE IN THE
LAQUES BY CFM SCANNING. After conventional
ngioscopy and CFA, the 4- to 5-mm-long
ortion in which the observed plaque was located
as isolated by transecting its proximal and the
istal ends at the shorter axes to avoid plaque
amage. The isolated segment was subsequently
ut longitudinally to open the lumen, mounted
n a deck glass, and the luminal surface was
canned by CFM at a magnification of 40 using
lters for A-imaging in 25 coronary arteries.
istology. After scanning the plaque through
-imaging of CFM, its center was cut into slices.
hese were stained with Oil Red-O and methylene
lue (thus staining the lipids red and the calcium
lack). The remaining adjacent slices were fixed
ith formaldehyde and cut into successive slices.
Figure 1. Fluorescence of Collagen Subtypes Visualized by A-Im
(A to D) Fluorescence color of collagens I, III, IV, and V, respectively
III, light blue ﬂuorescence in collagen IV, and no ﬂuorescence in co
color. (F) Mixture of collagen I and beta-carotene showing green in
ing white-to-light blue in ﬂuorescence. Horizontal bar of each panel everal slices were taken to stain the CFs present
ithin them by silver staining.
Normal CFs were those that were 5 to 15 m
n diameter and reddish brown in color. Collagen
bers 15 m in diameter were called “thick-
ned” CFs, and ones with a collapsed or thread-
ike configuration were defined as “degenerated”
Fs. The CFs were considered to be absent if the
ormal or thickened CFs did not appear. Cer-
mide is a marker of macrophage and foam cells
11). This substance was photographed by CFM
hrough B-imaging, because it exhibited orange
uorescence after Ziehl-Neelsen staining. Differ-
ntiation between the macrophages and foam
ells was difficult because both of them contain
eramide. They were therefore collectively called
macrophage foam cells” in the present study.
bservation of Ox-LDL in the coronary plaques in
atients with coronary artery disease by CFA. All the
atients provided informed consent for the proce-
ures carried out, which were further approved by
he Institutional Review Board of the Toho Uni-
ersity Sakura Hospital.
Seven patients suffering from stable angina pec-
oris (6 men and 1 woman; 62.1  2.2 [mean 
E] years of age) underwent CFA using filters for
-imaging.
g of CFM Before and After Mixing with Beta Carotene
e ﬂuorescence was seen in collagen I, no ﬂuorescence in collagen
n V. (E) Beta carotene (10–5 mol/l) showing orange in ﬂuorescent
rescent color. (G) Mixture of collagen III and beta-carotene show-agin
. Blu
llage
ﬂuo100 m. CFM  color ﬂuorescent microscopy.
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402After confirming plaque location by coronary an-
iography, an angioscope was introduced into the
rtery for observation of the targeted plaque by con-
entional angioscopy. Both BPF and BAF were sub-
equently set for B-imaging of CFA. After observa-
ion of autofluorescence of the plaque, 1 ml of 2% EB
olution was injected into the artery and CFA was
epeated to detect fluorescence that was specific to
x-LDL. Details of the procedure for intracoronary
dministration of EB are described elsewhere (3).
tatistical analysis. The obtained data were evalu-
ted by Fisher exact test, and p  0.05 was
onsidered significant. The authors had full access
o the data and are responsible for its integrity. All
oncerned authors have read the manuscript and
gree with its content as written.
E S U L T S
luorescence of the substances that constitute human
therosclerotic plaques examined by CFM. Among the
ajor substances that constitute atherosclerotic plaques,
ollagen I and IV exhibited blue and light blue autofluo-
escence, respectively, whereas collagen III and V did
ot. Blue or light blue autofluorescence was not exhibited
y any other substances. Calcium phosphate exhibited
hite autofluorescence, and beta carotene exhibited or-
nge autofluorescence (Fig. 1, Table 1).
Figure 2. Fluorescence of Lipids
(A, B, D, E) A-imaging of CFM. (C, F) B-imaging of CFM. (A) White a
oleate. (C) No autoﬂuorescence of Ox-LDL. (D) Yellow ﬂuorescence
of the cholesteryl oleate excited by beta carotene. (F) Reddish brow
panel  100 m. EB  Evans blue dye; Ox-LDL  oxidized low-densityIn the presence of beta carotene, collagen I and
V exhibited green fluorescence, collagen III and V
howed white fluorescence, cholesterol exhibited
ellow fluorescence, and CEs showed orange fluo-
escence (Figs. 1 and 2, Table 1).
luorescence of Ox-LDL examined by CFM. Ox-LDL
id not show autofluorescence, but presented a
eddish brown fluorescence in the presence of EB
Fig. 2). This fluorescent color was not exhibited by
ny other major substances in the atherosclerotic
laques, indicating that this fluorescent color was
ue to Ox-LDL (Table 1).
utoﬂuorescence of excised human coronary plaques
xamined by CFA and CFM scanning. RELATIONSHIPS
ETWEEN THE CFA IMAGES AND CFM SCANNED
MAGES. When observed by A-imaging of CFA,
hite plaques observed during conventional an-
ioscopy exhibited blue fluorescence as in the case
f apparently normal coronary segments, whereas
ellow plaques observed during conventional an-
ioscopy exhibited green, white-to-light blue, or yellow-
o-orange fluorescence (Figs. 3 and 4, Table 2).
The blue plaques observed during CFA also
xhibited blue fluorescence during CFM scanning.
he green plaques observed during CFA exhibited
reen or green and blue in a mosaic fashion during
FM scanning. The white-to-light blue plaques
bserved during CFA exhibited yellow substances
uorescence of cholesterol. (B) No autoﬂuorescence of cholesteryl
e cholesterol excited by beta carotene. (E) Orange ﬂuorescence
uorescence of the Ox-LDL excited by EB. Horizontal bar of eachutoﬂ
of th
n ﬂlipoprotein; other abbreviations as in Figure 1.
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403n white-to-light blue area during CFM scanning.
he yellow-to-orange plaques observed during
FA exhibited orange, white, and/or blue sub-
tances in the area where fluorescence was absent
uring CFM scanning (Figs. 3 and 4, Table 3).
ELATIONSHIPS BETWEEN CFA IMAGES AND HIS-
OLOGY. In the plaques that exhibited blue fluo-
escence by CFA, a histological examination re-
ealed that lipids were not deposited, the intima
as composed of normal CFs, and macrophage
oam cells were not found.
In the plaques that exhibited green fluores-
ence by CFA, both CFs and lipids were abun-
ant, but macrophage foam cells were not found.
In the plaques that exhibited white-to-light blue
uorescence by CFA, lipids were abundant, CF
ere degenerated and reduced in number, and
acrophage foam cells were distributed not only
n deep layers but also in superficial layers.
In the plaques that exhibited yellow-to-orange
uorescence by CFA, a lipid core was present
eneath a thin fibrous cap, and CFs in the fibrous
Figure 3. Relationships Between Images Produced by Conventio
(A to D) Conventional angioscopic images of coronary plaques. (a t
sponding CFM scanned images using A-imaging. Horizontal bar 
copy (arrow) exhibited blue ﬂuorescence by CFA (arrow in a) and C
angioscopy (arrow) exhibited green ﬂuorescence seen during CFA (
during conventional angioscopy (arrow) exhibited white-to-light blue
the white-to-light blue area (arrow in ). (D) A yellow plaque observed
observed during CFA (d) and deposition of orange (white arrowhead)
no ﬂuorescence by CFM scanning. CFA  color ﬂuorescent angioscopyap were almost absent. Lipids, calcium particles, tnd macrophage foam cells were distributed in the
brous cap (Figs. 3 and 4, Table 4).
x-LDL in human coronary plaques examined
y CFA. When observed by B-imaging of CFA,
hite plaques observed by conventional angioscopy
xhibited green fluorescence as in the case of an
pparently normal coronary segment. Yellow
laques observed by conventional angioscopy exhib-
ted green and yellow fluorescence in a mosaic pattern
r yellow-to-orange fluorescence (Table 5). After the
dministration of EB, not only the yellow plaques
ut also the white plaques studied by conventional
ngioscopy frequently presented a reddish brown
uorescence by B-imaging, indicating the existence
f Ox-LDL (Fig. 5). The distribution of this
uorescence appeared in a patchy or diffuse manner.
here was a tendency for this fluorescent color to
ppear more frequently in yellow plaques rather
han the white plaques classified by conventional
ngioscopy (Fig. 5, Table 5).
x-LDL in coronary arteries of patients with
oronary artery disease. After selective injection
f the EB solution into the coronary artery, not only
Angioscopy, CFA, and CFM Scanning
) Corresponding CFA images using A-imaging. ( to ) Corre-
m. (A) A white plaque observed during conventional angios-
scan (). (B) A yellow plaque observed during conventional
w in b) and CFM scan (arrow in ). (C) A yellow plaque observed
escence seen during CFA (c) and deposition of yellow substances in
ring conventional angioscopy (arrow) exhibited yellow ﬂuorescence
ite (white arrow), and blue (yellow arrow) substances in the area of
her abbreviations as in Figure 1.nal
o d
100
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404egments frequently exhibited a reddish brown
uorescence, indicating the existence of Ox-LDL
Fig. 6, Table 5).
Serious complications were not observed during
nd after the CFA.
I S C U S S I O N
oronary plaques have been classified into white
nd yellow color by conventional angioscopy, and
Figure 4. Lipids, Calcium Compounds, CFs, and Macrophage Fo
(A to D) Microscopic images after Oil-red O and methylene blue sta
Figure 3, respectively. Red  lipids; black  calcium. Horizontal ba
normal CFs in d. (Arrow in d) Plaque debris. Horizontal bar  20 
by B-imaging of CFM after Ziehl-Neelsen staining. Orange ﬂuoresce
bar  20 m. (A) A plaque without lipids, with abundant normal C
ids, with thick CFs (b) but without macrophage foam cells (). (C) A
and disseminated macrophage foam cells (arrow in ). (D) A plaqu
out CFs (d), and with multiple macrophage foam cells (arrows in 
Figure 1.
s Between Images Produced by A-Imaging of CFA and
al Angioscopy
ues by conventional White plaques Yellow plaques
27 30
ues by CFA (A-imaging)
27 1*
reen in mosaic pattern 0 12†
0 8‡
0 9†
p  0.05 versus white plaques.pangioscopy.he plaques exhibiting a yellow color are believed to
e vulnerable (3–5).
Conventional angioscopy cannot discriminate
he substances or cells that contribute to the stabil-
ty and instability of plaques. It is therefore consid-
red to be a suboptimal method to obtain images of
ulnerable plaques.
Using the A-imaging of CFA, the white plaques
tudied during conventional angioscopy exhibited
lue fluorescence, whereas yellow plaques demon-
trated 3 different categories of fluorescent colors.
herefore, the substances in the plaques that deter-
ine these fluorescent colors were examined. The
resent study also evaluated the relationship be-
ween fluorescent colors and the histological
hanges that characterize stable and vulnerable
laques.
Based on the findings of this study, the nature of
uorescent colors and their relationships to plaque
ulnerability can be explained as follows.
ature of blue ﬂuorescence in plaques. All white
Cells in the Same Plaques as Those Shown in Figure 3
g obtained from the same plaques in A, B, C, and D as shown in
100 m. (a to d) Collagen ﬁbers stained by silver staining. No
( to ) Images of ceramide in macrophage foam cells obtained
(arrows)  ceramide. (Arrowhead in ) Residual CFs. Horizontal
a) and without macrophage foam cells (). (B) A plaque with lip-
que with lipid deposition and cavity formation, meager CFs (c)
th a thin ﬁbrous cap with lipids and calcium (arrow in D), with-
s  collagen ﬁbers; LC: lipid core; other abbreviations as inam
inin
r 
m.
nce
Fs (
pla
e wi
). CFTable 2. Relationship
Those by Convention
Color of coronary plaq
angioscopy
Number of plaques
Color of coronary plaq
Blue
Green, or blue and g
White-to-light blue
Yellow-to-orange
*p  0.0001, †p  0.01, ‡laques studied through conventional angioscopy
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405xhibited blue fluorescence. Blue fluorescence
as specific to collagen I, so it was considered
hat the plaques were composed of CFs that
ontained collagen I. Histological examinations
evealed the existence of normal CFs and the
bsence of lipids. Blue plaques were therefore
onsidered to be stable.
ature of green ﬂuorescence in plaques. Plaques that
xhibited green fluorescence during CFA showed
diffusely green or green and blue fluorescence
rranged in a mosaic fashion during CFM scan-
ing. because the mixture of collagen I and IV
ith beta-carotene, which coexists with lipids in
he human vascular wall, exhibited green fluores-
ence, it is likely that both the lipids and CFs that
ontain collagen I and/or IV coexisted in the
laques. Histological examinations revealed that
hese plaques were rich in both lipids and CFs.
ven if they have a large diameter, it is likely that
hese abundant CFs protect the plaques against
echanical stress, and therefore the plaques were
onsidered to be stable.
Table 3. Relationships Between Images Produced by A-Imaging
Color of coronary plaques by CFA (A-imaging)
Number of plaques
CFM scanned image (A-imaging)
Blue
Green or blue and green in mosaic pattern
Yellow substances in white or light blue area
Orange, white, and/or blue substances in area of no ﬂuorescence
*p  0.01 and †p  0.05 versus blue group. ‡p  0.05 versus green group.
white-to-light blue group.
Abbreviations as in Tables 1 and 2.
Table 4. Relationships Between Images Produced by A-Imaging
From the Plaque Surface
Color of coronary plaques by CFA (A-imaging) Blue
Number of plaques 28
Histology
Lipid core 0
Lipids 1
Calcium 0
Macrophage foam cells 1
Collagen ﬁbers
Normal 19
Thickened 9
Degenerated but abundant in number 0
Degenerated and meager in number 0
Almost absent 0
*p  0.001 versus blue group. †p  0.05 versus green group. ‡p  0.01 and §p
group. #p  0.05 versus white-to-light blue group.
Abbreviations as in Table 1.ature of white-to-light blue ﬂuorescence in plaques.
laques, that exhibited white-to-light blue fluo-
escence during CFA, showed deposition of yel-
ow substances in the white-to-light blue area
uring CFM scanning. Because cholesterol ex-
ibited yellow fluorescence in the presence of
eta-carotene, the yellow substances observed
uring CFM scanning may have been mainly
holesterol.
Collagens III and V exhibited white fluorescence
n the presence of beta-carotene, so the white area
bserved during CFM scanning may have been
ccupied by collagens III and/or V. The light blue
rea may have been due to the presence of CFs that
ontain collagen IV without beta carotene; the
laque as a whole therefore exhibited white-to-light
lue fluorescence during CFA.
Histological examinations revealed deposition
f lipids, the presence of small lipid pools, meager
Fs and the presence of macrophage foam cells
ven in the superficial layers. These findings
ndicate that the plaques were becoming vulner-
FA and Those by CFM Scanning
Blue Green White-to-light Blue Yellow-to-orange
28 12 8 9
28 0* 0† 0†
0 12* 0‡ 0‡
0 0 8§ 0¶
0 0 0 9§¶
0.001 versus blue group. p  0.01 versus green group. ¶p  0.05 versus
FA and Histological Changes Within a Depth of 200 m
Green White-to-light Blue Yellow-to-orange
12 8 9
1 6* 8†
12* 8 9
2 2 7*
3 6‡ 9
1§ 0§ 0§
9 0† 0†
2 0 0
0 8¶ 1
0 0 8¶#
.05 versus blue group. p  0.0001 versus blue group. ¶p  0.01 versus greenof C
§p of C
 0
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406ble and were therefore considered to be rela-
ively vulnerable.
ature of yellow-to-orange ﬂuorescence in plaques.
laques, that exhibited yellow-to-orange fluores-
ence during CFA, showed deposition of orange,
hite, and blue substances in the area that
howed no fluorescence during CFM scanning.
Es, accumulated in macrophage foam cells (9),
xhibited orange fluorescence in the presence of
x-LDL in an Excised Coronary Plaque Imaged by CFA
plaque imaged by conventional angioscopy; the arrow shows
observed by CFA. (B) The CFA image of the same plaque before
ion of EB. The plaque showed green autoﬂuorescence, indicating
f collagens I and/or IV (Table 1). (C) The CFA image after admin-
EB. The plaque showed diffuse and reddish brown ﬂuorescence,
the existence of Ox-LDL. (D) Histology of the same plaque after
th Oil Red-O and methylene blue dye. Red  lipids. Lipids were
not in the superﬁcial layer but in the deep layer. Horizontal bar
Table 5. Ox-LDL in Human Coronary Plaques Visualized by CFA
Conventional Angioscopy n
Ox-LDL in excised human coronary plaques
White plaques 16
Yellow plaques 15
Ox-LDL in the coronary arteries in patients with coronary artery dis
Apparently normal segments 6
White plaques 7
Yellow plaques 5
NS  no signiﬁcant difference among the groups; Ox-LDL  oxidized low-dent
. L  lumen; other abbreviations as in Figures 2 and 3.eta-carotene, so the orange substances may have
een CEs. Calcium compounds were the only
ubstance that exhibited white fluorescence, so
he observed white substances may have been due
o calcium compounds. Blue fluorescence was
pecific to collagen I; therefore the blue sub-
tances may have been the disrupted CFs con-
aining collagen I not conjugated to beta-
arotene. The area of no fluorescence may have
een due to the deposition of the substances that
o not exhibit fluorescence (e.g., Ox-LDL). The
ixture of these colors may have therefore caused
he appearance of yellow-to-orange fluorescence
uring CFA.
Histological examinations revealed a thin fi-
rous cap deposited with lipids, calcium particles,
nd macrophages foam cells, and absent in CFs.
hese plaques were therefore considered to be
he most vulnerable ones.
x-LDL. The use of an antibody against Ox-LDL
s a more specific method for imaging of Ox-
DL in vivo (9), but there are many limitations
nd hard lines for its clinical application. There-
ore, the use of a low molecular weight substance
hat selectively binds to Ox-LDL and presents a
uorescent color is another option that can be
sed for the imaging of Ox-LDL in vivo. There-
ore, in this study, a substance that presents
uorescence when conjugated to Ox-LDL was
earched for. Evans blue dye was discovered to
voke a reddish brown fluorescence when added
o Ox-LDL during B-imaging of CFM. The
echanisms by which EB evoked the fluores-
ence of Ox-LDL are not known, but EB and
x-LDL may conjugate to form an adduct to
enerate this fluorescent color. Because there
ere no other known substances that presented
B-Imaging of CFA
Autoﬂuorescence Ox-LDL
n in 16 7 (43%) NS
13 (86%) NS
n and yellow in a mosaic pattern in 2 1
w-to-orange in 13 12
n in 6 2 (33%) NS
n in 7 5 (71%) NS
w-to-orange in 5 4 (80%) NS
ipoprotein; other abbreviations as in Table 2.Figure 5. O
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407haracteristic fluorescent color was exhibited by
x-LDL and that EB can be used as its
ndicator.
Reddish brown fluorescence indicating exis-
ence of Ox-LDL was observed not only in
ellow and white plaques but also in apparently
ormal coronary segments classified by conven-
ional angioscopy. This finding suggests that
x-LDL deposits preceded other lipids. There is
ell-known evidence that Ox-LDL is a pro-
nflammatory and pro-atherogenic substance, and
t plays an important role in initiation of athero-
clerosis (20). Therefore, the findings of this
tudy are in accordance with this fact.
Further studies on the relationships between
he deposition of the substances and cells that
omprise atherosclerotic plaques and the images
btained by color fluorescent angioscopy, intra-
ascular ultrasonography, optical coherence to-
ography, and Raman spectroscopy (21) may
rovide much more valuable information on the
ulnerable plaques.
O N C L U S I O N S
FA revealed that the yellow coronary plaques
Figure 6. Ox-LDL Imaged by CFA in the Coronary Artery in a Pa
Reddish brown ﬂuorescence observed in a nonstenotic proximal se
coronary injection of EB in a patient with stable angina pectoris. (A
segment observed by CFA. The wall of the segment was uneven bu
same segment obtained after injecting EB, by advancing the angios
LDL. The luminal surface was uneven, indicating early stage of athebserved by conventional angioscopy, were fur- ther classified into green, white-to-light blue, and
ellow-to-orange plaques. Studies on the fluores-
ence of the major substances that comprise
laques indicated that the presence or absence of
ollagen subtypes, cholesterol, CEs, calcium, and
eta-carotene determines the fluorescent color of
he plaques. Histological examinations revealed
hat the plaques presenting yellow-to-orange flu-
rescence had a thin fibrous cap deposited with
ipids, calcium, and macrophage foam cells but
ere devoid of normal CFs that protect the
laque against mechanical stress, indicating that
hese plaques were the most vulnerable. Ox-
DL, which plays an important role in the
nitiation, progression, and destabilization of the
laques, was also visualized by CFA using EB as
n indicator. Thus, molecular or chemical imag-
ng by CFA provides much more objective infor-
ation on vulnerable coronary plaques than con-
entional angioscopy.
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